BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1092302)

  • 1. Mechanisms of action of 6-hydroxydopamine.
    Sachs C; Jonsson G
    Biochem Pharmacol; 1975 Jan; 24(1):1-8. PubMed ID: 1092302
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 2-and/or 5-methylated analogues of 6-hydroxydopamine on norepinephrine-and dopamine-containing neurons.
    Liang YO; Adams RN
    Mol Pharmacol; 1977 Sep; 13(5):805-18. PubMed ID: 895717
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro inhibition of brain mitochondrial monoamine oxidase by 6-hydroxydopamine.
    Youdim MB
    Br J Pharmacol; 1975 Jul; 54(3):403-5. PubMed ID: 1164597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-methoxy-4-hydroxyphenylglycol excretion and behavioural changes in rat and monkey after central sympathecomy with 6-hydroxydopamine.
    Breese GR; Prange AJ; Howard JL; Lipton MA; McKinney WT; Bowman RE; Bushnell P
    Nat New Biol; 1972 Dec; 240(104):286-7. PubMed ID: 4633263
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inadequacy of the monoamine oxidase system--the probable pathogenetic factor in schizophrenia (review)].
    Kolpakov VG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(8):1254-63. PubMed ID: 4278558
    [No Abstract]   [Full Text] [Related]  

  • 6. Excretion of catecholamine metabolites following intraventricular injection of 6-hydroxydopamine in the Macaca speciosa.
    Maas JW; Dekirmenjian H; Garver D; Redmond DE; Landis DH
    Eur J Pharmacol; 1973 Aug; 23(2):121-30. PubMed ID: 4200289
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
    Nguyen TB; Angers M
    Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central effects of 6-hydroxydopamine.
    Longo VG
    Behav Biol; 1973 Oct; 9(4):397-420. PubMed ID: 4200735
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimation of the contribution of peripheral and central noradrenergic neurones to urinary 3-methoxy-4-hydroxyphenylglycol in the rat.
    Karoum F; Wyatt R; Costa E
    Neuropharmacology; 1974 Mar; 13(3):165-76. PubMed ID: 4840872
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of morphine tolerance and physical dependence in rats depleted of brain catecholamines by 6-hydroxydopamine.
    Elchisak MA; Rosecrans JA
    Neuropharmacology; 1979 Feb; 18(2):175-82. PubMed ID: 571053
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of central catecholamine alterations by 6-hydroxydopamine on shuttle box avoidance acquistion.
    Cooper BR; Breese GR; Howard JL; Grant LD
    Physiol Behav; 1972; 9(5):727-31. PubMed ID: 4655165
    [No Abstract]   [Full Text] [Related]  

  • 12. Regional changes in [3H]-noradrenaline uptake, catecholamines and catecholamine synthetic and catabolic enzymes in rat brain following neonatal 6-hydroxydopamine treatment.
    Jonsson G; Sachs C
    Med Biol; 1976 Aug; 54(4):286-97. PubMed ID: 8670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adaptation to the behavioral effects of 6-hydroxydopamine].
    Semenova TP; Tret'iak TM; Grishchenko NI; Smirnova GN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1983; 33(1):163-5. PubMed ID: 6404069
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the uptake and subcellular distribution of catecholamines and their alpha-methylated analogues.
    Lundborg P
    Acta Physiol Scand Suppl; 1967; 302():1-34. PubMed ID: 5584149
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
    Green AR; Mitchell BD; Tordoff AF; Youdim MB
    Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of central effects of 6-aminodopamine and 6-hydroxydopamine on catecholamine levels.
    Oke A; Freeman R; Adams RN
    Eur J Pharmacol; 1974 Apr; 26(1):125-7. PubMed ID: 4831981
    [No Abstract]   [Full Text] [Related]  

  • 17. The pharmacology of 6-hydroxydopamine.
    Thoenen H; Tranzer JP
    Annu Rev Pharmacol; 1973; 13():169-80. PubMed ID: 4576887
    [No Abstract]   [Full Text] [Related]  

  • 18. Asymmetric behavioral and biochemical effects of unilateral injections of 6-hydroxydopamine into the lateral brain ventricle of the rat.
    Vetulani J; Reichenberg K; Wiszniowska G
    Eur J Pharmacol; 1972 Aug; 19(2):231-8. PubMed ID: 5071793
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological actions of 6-hydroxydopamine.
    Kostrzewa RM; Jacobowitz DM
    Pharmacol Rev; 1974 Sep; 26(3):199-288. PubMed ID: 4376244
    [No Abstract]   [Full Text] [Related]  

  • 20. Learning impairment in rats after 6-hydroxydopamine-induced depletion of brain catecholamines.
    Mason ST; Iverson SD
    Nature; 1974 Apr; 248(5450):697-8. PubMed ID: 4151498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.